______________________________________________________________________________________________________ Agenus Bio
▲ Upstream Production Ballroom Suite
▲ Packaging and Labeling
“ We ’ re aiming to create an entirely selfsufficient facility . With our best-in-class equipment , and higher rates of production , we can manufacture biological therapies and solutions at a larger scale , and with greater efficiency , ensuring faster access for patients in need .
“ This facility allows us to go from cell line development to cell engineering , all the way through to drug product production and commercialization . Our in-house capabilities even extend to packaging , labelling , sterilization , aggregation , warehousing , and distribution . Further , it feeds back into the development pipeline , by providing a quicker turnaround on trial outcomes . We ’ re always keeping the patient in mind — we want to deliver the drugs to them as quickly , and as cost efficiently as possible .
“ The facility ’ s advanced systems , including four 2,000L upstream production bioreactors ,
Your world leading CDMO .
As a respected industry leader and trusted partner , we provide a comprehensive range of pharmaceutical services from the earliest stages of development through to commercial launch and ongoing supply .
Our CDMO services include :
• Development & Manufacturing
• Clinical Trial Services
• Advanced Drug Delivery & Drug Device Combination Products
• Commercial Packaging Technology
Supported by speedsolutions ™
Together , delivering life changing therapies | Let ’ s talk future ™ talkfuture @ pci . com | pci . com
EOM 1546 PCI Pharma Services Corporate ad 182x131mm ( 2 ). indd 1 12 / 11 / 2024 14:37 manufacturing-today . com 185